Xphyto’s test may be ideal to catch the super-spreaders – the infectious carriers blithely attending drumming circles because they feel healthy….
drug delivery systems
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto….
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly….
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….
We’re two months in on this pandemic and governments are thinking about reopening the economy for the summer when the traditional flu season winds down. Granted, there’s more than…
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple…
Xphyto Therapeutics (XPHY.C) announced today that they advancing its thin film CBD delivery system for epilepsy sufferers to clinical trials. In the past three months, the company’s German subsidiary,…
Aleafia Health’s (ALEF.C) subsidiary, Emblem Cannabis, has signed a licensing agreement with Kinstate Inc, to bring Kin’s sublingual cannabis strips brand and tech to the Canadian medical and adult-use…
Pivot Pharmaceuticals (PVOT.C) launched its manufacturing facility in Dollard-des-Ormeaux, Quebec, today. It’s intended primarily for research and development and pilot-scale laboratories, and compromises 43,000 square feet of production and…